ArticleFrontiers in pharmacology2026
CPNE7-derived peptides CDP4 and UG28 as pro-angiogenic factors for endothelial regeneration.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeEfficient endothelial regeneration is fundamental to microcirculatory restoration and hard tissue repair. CPNE7 family peptides have previously been shown to regulate osteogenesis and chondrogenesis, however, their involvement in vascular reconstruction has not been explored. EXPERIMENTAL APPROACH: In this study, we investigated the effect of two peptides derived from CPNE7, CDP4 and UG28, on human endothelial cells KEY
resultsUG28 demonstrated the strongest pro-angiogenic activity, enhancing EC proliferation, directional migration, and pseudocapillary network formation, while CDP4 also promoted migration and early vascular organization; neither peptide showed cytotoxicity nor induced immune activation, and both were compatible with chitosan matrices. CONCLUSION AND IMPLICATIONS: CPNE7-derived peptides-especially UG28-are potent and safe pro-angiogenic agents with high translational potential, and their compatibility with chitosan supports their applicability in next-generation regenerative therapies targeting endothelial and microvascular repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.